New York, October 28, 2015 – Cellectis (Alternext: ALCLS – Nasdaq: CLLS) today announced that a series of three production runs of UCART19, its lead TALEN® gene edited product candidate, was performed ...
Colombian and Mexican GMP certifications expected during Q1'21 and Q2'21, respectively The Company confirms that its recently completed Processing and Extraction Center at its Rionegro facility, ...
Small biotechs in early development of cell therapies are often surprised by the strictness of commercial manufacturing standards. That’s the view of Luděk Sojka, PhD, CEO of contract developer and ...
Eurofins CDMO Amatsiaquitaine S.A.S., the GMP manufacturer, to support Polyrizon in future commercialization efforts Raanana, Israel, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (PLRZ) (the ...
Dublin, April 15, 2026 (GLOBE NEWSWIRE)-- The "Process Validation for Medical Devices (June 4th - June 5th, 2026)" training has been added to ResearchAndMarkets.com's offering. Process validation is ...
Dublin, April 15, 2026 (GLOBE NEWSWIRE)-- The "Process Validation with Qualification (June 3rd - June 4th, 2026)" training has been added to ResearchAndMarkets.com's offering. Ensure your ...
Welcome to our Asia Regulatory Roundup, our weekly overview of the top regulatory news in Asia. The Therapeutic Goods Administration (TGA) of Australia has released guidance and a web-based tool to ...
HARd is HYTN’s proprietary remediation process for dried cannabis flower, developed and validated within the Company’s GMP quality systems. The process is designed to reduce microbial burden while ...
Australia’s Therapeutic Goods Administration (TGA) has revised its process for handling the closeout of on-site good manufacturing practice (GMP) inspections. The updated process ends the practice of ...
Cannabis company Flora Growth Corp. FLGC announced Tuesday that its wholly-owned subsidiary, Cosechemos, has produced the first batch of crude oil through its newly constructed extraction facility.
NEW YORK--(BUSINESS WIRE)--Regulatory News: Cellectis (Paris:ALCLS) (NASDAQ:CLLS) (Alternext: ALCLS – Nasdaq: CLLS) today announced that a series of three production runs of UCART19, its lead TALEN ® ...